UK study tracks rare muscle disease to pave way for future treatments
NCT ID NCT06670378
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 45 people with nemaline myopathy in the UK to learn how the disease naturally progresses. Researchers collect medical exams, quality-of-life surveys, and physical assessments over time. The goal is to identify the best ways to measure the disease in future clinical trials. No new treatments are tested here.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEMALINE MYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Paediatric Neurology - Neuromuscular Service, Evelina Children's Hospital
London, United Kingdom
-
Dubowitz Neuromuscular Centre, UCL Great Ormond Street Hospital
London, United Kingdom
-
John Walton Muscular Dystrophy Research Centre, Newcastle University
Newcastle, United Kingdom
-
MDUK Oxford Neuromuscular Centre, University of Oxford
Oxford, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.